3186 results for «3689»

Filter By

3186 results

Optimal SCAD treatment

22 May 2025 – From EuroPCR 2025

Navigate the complexities of spontaneous coronary artery dissection (SCAD) treatment through clinical case discussions. This session explores identifying the culprit lesion, recurrent ACS challenges, the conservative versus PCI treatment dilemma, and real-world presentation scenarios emphasizing decision-making in SCAD management.

Optimal SCAD treatment

PCI in a challenging coronary anatomy

22 May 2025 – From EuroPCR 2025

This session tackles PCI in challenging coronary anatomies, featuring cases with anomalous coronary arteries, complex access routes, and specialized stenting techniques. Learn from experiences managing dual anomalous arteries, navigating to difficult lesions, and applying innovative modified chimney stent methods to restore coronary flow.

PCI in a challenging coronary anatomy

When angina cannot be cured with stents: what are the remaining options

22 May 2025 – From EuroPCR 2025

Explore therapeutic options for patients with angina refractory to stenting. This session reviews the efficacy and clinical outcomes of coronary sinus (CS) reducer implantation for microvascular dysfunction, factors influencing procedural success, next-generation CS reducer innovations, and the role of aspirin in angina without obstructive coronary disease.

When angina cannot be cured with stents: what are the remaining options

Combined LAA closure and transcatheter mitral valve repair - LIVE Case

22 May 2025 – From EuroPCR 2025

An 82-year-old male patient with a history of PM (pacemaker) implantation in 2024, and ischaemic cardiomyopathy presented with symptomatic heart failure due to severe secondary mitral regurgitation and impaired LV function (EF 40 %). He also presented with recurrent gastro-intestinal bleeding while on DOAC for atrial...

Combined LAA closure and transcatheter mitral valve repair - LIVE Case

Beyond the intervention: outcomes of CTO PCI

22 May 2025 – From EuroPCR 2025

Discover long-term outcomes and practical insights into chronic total occlusion (CTO) PCI. This session presents real-world registry data, cost-effectiveness analyses, effects of successful revascularisation in reduced ejection fraction and heart failure patients, and specific outcomes in octogenarian populations.

Beyond the intervention: outcomes of CTO PCI

TAVI - Outcomes predictors

22 May 2025 – From EuroPCR 2025

Examine novel predictors of outcomes following TAVI. This session compares a new nutritional risk index against traditional scores for early post-TAVI mortality prediction and evaluates uric acid as a marker for aortic valve calcification and mortality risk in TAVI patients.

TAVI - Outcomes predictors

Redo TAVI - How to treat different TAVI platforms when they fail

22 May 2025 – From EuroPCR 2025

Understand the complexities of redo TAVI procedures with emphasis on planning, valve platform characteristics, and tailored procedural strategies. This session features cases of redo TAVI for failed short-frame and tall-frame valves, alongside discussions on current evidence gaps guiding optimal management.

Redo TAVI - How to treat different TAVI platforms when they fail

Retrograde removal of the broken sheath

22 May 2025 – From EuroPCR 2025

This session addresses complex complications during vascular access with a focus on retrograde removal of broken sheaths. Learn to recognize critical signs, manage rare but severe complications including broken guidewires in the radial artery, and explore innovative off-label solutions for challenging scenarios.

Retrograde removal of the broken sheath

TAVI for aortic regurgitation off label

22 May 2025 – From EuroPCR 2025

Explore off-label applications of TAVI for aortic regurgitation in complex clinical scenarios. Topics include TAV-in-SAV with Trilogy valve for severe regurgitation, challenges of transcatheter prosthesis in pure aortic regurgitation, management of surgical valve perforations, and treatment strategies in post-surgical anatomies including degenerative homografts and aortic dissection.

TAVI for aortic regurgitation off label

High thrombus burden in STEMI

22 May 2025 – From EuroPCR 2025

This session addresses the management of high thrombus burden in STEMI patients. It reviews available tools and strategies for thrombus management, presents multiple case-based discussions illustrating treatment decisions, and explores the evolving role of thrombus aspiration in contemporary practice.

High thrombus burden in STEMI

Procedural planning and risk stratification in multivessel PCI

22 May 2025 – From EuroPCR 2025

This session focuses on procedural planning and risk stratification in multivessel PCI, presenting data from the TALENT and FIRE trials, prognostic value of post-PCI physiological assessments, and an innovative study comparing large language models in managing complex interventional cardiology cases.

Procedural planning and risk stratification in multivessel PCI

What did we learn from my TAVI complications?

22 May 2025 – From EuroPCR 2025

Review critical lessons from TAVI complications, focusing on early identification and management of access site issues and acute coronary obstruction. Learn effective preventive actions and procedural strategies to minimize severe TAVI-related complications through detailed case discussions.

What did we learn from my TAVI complications?

Clinical and technical factors for decision-making in treatment of left main coronary artery disease

22 May 2025 – From EuroPCR 2025

Delve into decision-making factors in treating left main coronary artery disease, particularly in challenging scenarios. This session discusses the application of new SOLACI guidelines, critical strategy reflections, and real-world cases illustrating optimal left main PCI approaches.

Clinical and technical factors for decision-making in treatment of left main coronary artery disease

Optimising TEER in challenging anatomies

22 May 2025 – From EuroPCR 2025

Optimize transcatheter edge-to-edge repair (TEER) strategies in challenging anatomies with focus on tricuspid valve interventions, recognition of multivalvular disease, and planning combined mitral and tricuspid TEER procedures. Case studies highlight feasibility challenges and dual valve repair approaches.

Optimising TEER in challenging anatomies

Atherectomy for CTO-PCI

22 May 2025 – From EuroPCR 2025

Explore atherectomy applications in CTO-PCI with cases demonstrating reverse cart technique, orbital atherectomy in heavily calcified occlusions, and management of atherectomy-induced coronary dissection. Gain practical insights into navigating complex CTO lesions with atherectomy support.

Atherectomy for CTO-PCI

Building bridges, not barriers: transforming communication with patients

22 May 2025 – From EuroPCR 2025

Enhance your communication skills with patients undergoing interventional cardiology procedures. This session emphasizes verbal and non-verbal techniques to inform and support patients, simplifying complex procedural explanations, and strengthening your role as the critical link between patients and the healthcare team for improved outcomes.

Building bridges, not barriers: transforming communication with patients

Outcome prediction using artificial intelligence and meta-analysis

22 May 2025 – From EuroPCR 2025

This session presents outcome prediction advancements through artificial intelligence and meta-analysis in cardiology. Topics include AI-guided aortic stenosis risk stratification, predictors of periprocedural stroke after TAVI, patient-specific computer simulations for bicuspid TAVI, and enhancements in large language model accuracy using Heart Team simulation.

Outcome prediction using artificial intelligence and meta-analysis

Pharmacotherapy coronary interventions: new insights

22 May 2025 – From EuroPCR 2025

Stay abreast of new insights in pharmacotherapy for coronary interventions with a focus on optimizing patient outcomes. Topics include ticagrelor monotherapy in chronic coronary syndrome post-PCI, analysis of multiple events in high bleeding risk patients from the MASTER DAPT trial, effects of beta-blocker interruption in MI...

Pharmacotherapy coronary interventions: new insights

Imaging makes it clear!

22 May 2025 – From EuroPCR 2025

Explore the critical role of intravascular imaging in interventional cardiology through real-world cases. This session highlights the value of intravascular ultrasound (IVUS) in avoiding unnecessary stenting in STEMI patients, the application of optical coherence tomography (OCT) in complex scenarios, and the management of calcified lesions with...

Imaging makes it clear!

Optimal use of cardiac imaging to plan and guide transcatheter LAA closure

22 May 2025 – From EuroPCR 2025

Optimize left atrial appendage (LAA) closure outcomes through expert use of cardiac imaging. This session details the role of various imaging modalities in pre-procedural planning, intraprocedural guidance, and post-procedural assessment. Gain practical insights on transesophageal echocardiography, computed tomography, intracardiac echocardiography, and their integration to enhance procedural...

Optimal use of cardiac imaging to plan and guide transcatheter LAA closure
Didn’t find what you were looking for?